---
document_datetime: 2024-02-08 13:09:26
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rivastigmine-actavis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: rivastigmine-actavis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.7003939
conversion_datetime: 2025-12-30 10:04:16.703598
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rivastigmine Actavis

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0032              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 07/02/2024                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IG/1612   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 31/05/2023   |            | SmPC, Labelling and PL   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|--------------------------|
| IAIN/0030 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 09/05/2022   | 05/05/2023 | Annex II and PL          |
| IA/0029/G | This was an application for a group of variations. B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer | 04/04/2022   | n/a        |                          |
| IB/0028   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 15/03/2022   | 07/06/2022 | SmPC, Labelling and      |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            | PL              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|
| IA/0027   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 09/04/2021 | 07/06/2022 | Annex II and PL |
| IA/0026   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 08/07/2020 | n/a        |                 |
| IB/0025   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 02/07/2019 | n/a        |                 |
| IA/0024/G | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the | 21/06/2019 | n/a        |                 |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|        | relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material) B.III.2.z - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Other   |            |            |                  |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|
| N/0023 | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 04/04/2018 | 07/06/2022 | PL               |
| N/0022 | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 24/07/2017 | 07/06/2022 | Labelling and PL |

<div style=\"page-break-after: always\"></div>

| IB/0020/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                     | 06/01/2017   | n/a        |                 |                             |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-----------------------------|
| IA/0021     | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                           | 05/01/2017   | n/a        |                 |                             |
| IAIN/0019/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer | 25/04/2016   | 16/02/2017 | Annex II and PL | responsible for importation |

<div style=\"page-break-after: always\"></div>

|             | including batch control/testing - Change to importer, batch release and quality control testing of the FP - or addition of a manufacturer for importation and/or batch release - including batch control/testing                                                                                                                                                                                                                                                                                                        |            |            |                        | Not B.II.b.2.c.1 arrangements Replacement responsible Not   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------|
| IAIN/0018/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - | 17/02/2016 | 16/02/2017 | Annex II and PL        | Not including batch                                         |
| R/0016      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 17/12/2015 | 15/02/2016 | Annex II and Labelling |                                                             |
| IB/0017     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                            | 07/12/2015 | 15/02/2016 | SmPC and PL            |                                                             |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IB/0015/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a   | 04/09/2015   | 15/02/2016   | SmPC, Annex II, Labelling and PL   |
|-------------|--------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            |                                  | new the                                           |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------|
| IB/0013/G   | This was an application for a group of variations. C.I.7.a - Deletion of - a pharmaceutical form C.I.7.b - Deletion of - a strength                                                                                                                                                                                                                                                                                                                                               | 03/06/2015 | 15/02/2016 | SmPC, Annex II, Labelling and PL |                                                   |
| IB/0014/G   | This was an application for a group of variations. B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.b.1.z - Change in the specification parameters AS, starting | 22/05/2015 | n/a        |                                  | and/or limits of an material/intermediate/reagent |
| IAIN/0012/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the                                                                                                                                                                                                                | 26/03/2015 | n/a        |                                  | PSMF location                                     |

<div style=\"page-break-after: always\"></div>

| N/0011   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                     | 12/08/2014   | 15/02/2016   | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0010   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                     | 15/01/2014   | 15/02/2016   | PL                               | Update of details for local representatives in Annex IIIB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| N/0009   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                     | 16/08/2013   | 15/02/2016   | PL                               | Exchanging a graphic in the product information leaflet.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| II/0008  | To add an alternative manufacturer of the active substance (rivastigmine hydrogen tartrate) for manufacture of Rivastigmine capsules. B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a new manufacturer of the AS that is supported by an ASMF | 27/06/2013   | n/a          |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| X/0005   | Line extension (addition of new pharmaceutical form /new route of administration). Transdermal Patches of 4.6 mg/24 hours and 9.5 mg/24 hours. Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                         | 21/02/2013   | 17/04/2013   | SmPC, Annex II, Labelling and PL | The MAH applied for the addition of a new pharmaceutical form / new route of administration. Transdermal patches have been developed as generic products to Exelon transdermal patches (4.6 mg/24 hours and 9.5 mg/24 hours). The composition per unit area is identical for both strengths. The manufacturing process has been described and critical steps identified. Information on development, manufacture and control of this new pharmaceutical form has been presented. The product development has been described and several in vitro and in vivo proofs of concept clinical studies have been performed before the final composition was chosen and tested in a bioequivalence study. The in |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |             | vitro method chosen for the control of the drug substance prove similarity between the two strengths. Data has been provided showing that the method is discriminatory. The applicant has also presented data to ensure adhesion equivalence between the two dosage strengths.                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0007   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                                                                     | 11/07/2012 | n/a        | SmPC and PL | Update of SmPC and PL in line with updates of the originator's product Exelon/Prometax (WS-132) adopted on 16 March 2012. Update of section 4.8 of the SmPC to reflect the safety findings of the open-label safety study in patients with Parkinson's disease dementia. Additionally, sections 4.3 and 4.4 were updated with information on skin application site reactions and skin hypersensitivity, recommendations on formulation switching and treatment discontinuation. The Package Leaflet was updated in accordance. Minor editorial changes were introduced throughout the Product                                                                                        |
| IB/0006/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a | 12/03/2012 | 25/05/2012 | SmPC and PL | To update the SmPC and PL in line with updates of the originator's product Exelon/Prometax introduced in the work sharing procedures WS-119 and WS-121-G, which were adopted by the CHMP on 14 April 2011. The EMA variation request EMA/360627/2011 was dated 10 January 2012. C.I.2a) WS-119 included the following updates: Update of sections 4.3 and 4.4 of Exelon/Prometax oral formulations SmPC to change the contraindication for patients with severe hepatic impairment into a warning, in accordance with Exelon/Prometax transdermal patch SmPC. Section 4.4 of the SmPC for the oral formulations is also revised to reflect that patients with clinically significant |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                         |            |            |                        | Cyprus has been updated in sections 6 of the Package Leaflets.   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------|
| IB/0004   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                            | 12/01/2012 | n/a        |                        |                                                                  |
| IB/0003   | B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation                                                                                                                                                                                                                                                                              | 12/01/2012 | n/a        |                        |                                                                  |
| IB/0001/G | This was an application for a group of variations. B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings | 16/11/2011 | 25/05/2012 | SmPC, Labelling and PL |                                                                  |